Drug safety evaluation of alemtuzumab for multiple sclerosis. (2014)
Attributed to:
MRC Centre for Neuropsychiatric Genetics and Genomics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1517/14740338.2014.928691
PubMed Identifier: 24935240
Publication URI: http://europepmc.org/abstract/MED/24935240
Type: Journal Article/Review
Volume: 13
Parent Publication: Expert opinion on drug safety
Issue: 8
ISSN: 1474-0338